Roundhill Glp-1 & Weight Loss ETF (OZEM)
- Expense ratio0.58%
- Net assets$53.8M
- Dividend yield1.36%
- 1-year return+5.15%
- Holdings10
OZEM ETF price chart
OZEM quote & trading statistics
OZEM performance
Total return · as of October 18, 2026- YTD-12.89%
- 1 year+5.15%
- 1Y volatility
- 21.95%
- 3Y volatility
- 0.00%
- 3Y Sharpe ratio
- 0.00
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
OZEM top 10 holdings
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.29% |
| 2 | NVO | Novo Nordisk A/S | 11.01% |
| 3 | PFE | Pfizer Inc | 7.70% |
| 4 | 1093 | CSPC Pharmaceutical Group Ltd | 6.46% |
| 5 | KLRA | Kailera Therapeutics, Inc. Common Stock | 5.34% |
| 6 | VKTX | Viking Therapeutics Inc | 5.27% |
| 7 | 4519 | Chugai Pharmaceutical Co. Ltd. | 4.70% |
| 8 | AMGN | Amgen Inc | 4.56% |
| 9 | 1672 | Ascletis Pharma Inc | 4.44% |
| 10 | 128940 | Hanmi Pharm Co Ltd | 4.35% |
The top 10 holdings make up 66.1% of the fund (10 holdings in total). As of October 18, 2026.
About Roundhill Glp-1 & Weight Loss ETF
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
OZEM ETF FAQ
What is the OZEM expense ratio?
Roundhill Glp-1 & Weight Loss ETF has a net expense ratio of 0.58%, or $58.00 a year for every $10,000 invested.
How much money is in OZEM?
Roundhill Glp-1 & Weight Loss ETF has about $53.8M in net assets.
What are the top holdings of OZEM?
The largest positions in OZEM are Eli Lilly and Company (12.29%), Novo Nordisk A/S (11.01%), Pfizer Inc (7.70%). The fund holds 10 securities in total.
How has OZEM performed?
OZEM returned +5.15% over the past year, including reinvested distributions.
Does OZEM pay dividends?
OZEM has a dividend yield of 1.36%.
When was OZEM launched?
Roundhill Glp-1 & Weight Loss ETF began trading on May 20, 2024.
ETFs similar to OZEM
Funds that track the same index or whose top-10 holdings overlap most with OZEM's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.
| Symbol | Fund | Overlap | Expense ratio | Net assets | 1-year return |
|---|---|---|---|---|---|
| OZEM | Roundhill Glp-1 & Weight Loss ETF | — | 0.58% | $53.8M | +5.15% |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 51% | 0.58% | $5.7M | +2.90% |